Wnt3a is a promising target in colorectal cancer

被引：8
|
作者：
Tufail, Muhammad [1 ]
Wu, Changxin [1 ]
机构：
[1] Shanxi Univ, Inst Biomed Sci, Taiyuan 030006, Peoples R China
来源：
MEDICAL ONCOLOGY | 2023年 / 40卷 / 03期
关键词：
Wnt pathway; Wnt3a; Colorectal cancer; Chemoresistance; Angiogenesis; EPITHELIAL-MESENCHYMAL TRANSITION; PROSTATE-CANCER; ANGIOGENESIS; BEVACIZUMAB; GROWTH; INHIBITION; EXPRESSION; PATHWAY; COMBINATION; PROGRESSION;
D O I：
10.1007/s12032-023-01958-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Most colorectal cancers (CRC) are associated with activated Wnt signaling, making it the fourth most prevalent type of cancer globally. To function properly, the Wnt signaling pathway requires secreted glycoproteins known as Wnt ligands (Wnts). Humans have 19 Wnts, which suggest a complicated signaling and biological process, and we still know little about their functions in developing CRC. This review aims to describe the canonical Wnt signaling in CRC, particularly the Wnt3a expression pattern, and their association with the angiogenesis and progression of CRC. This review also sheds light on the inhibition of Wnt3a signaling in CRC. Despite some obstacles, a thorough understanding of Wnts is essential for effectively managing CRC.
引用
收藏
页数：12
相关论文
共 50 条
  • [21] A Promising Approach to Target Colorectal Cancer Using Hybrid Triarylmethanes
    Mohamed, Ameni Hadj
    Ricco, Christophe
    Pinon, Aline
    Lagarde, Nathalie
    Goya-Jorge, Elizabeth
    Mouhsine, Hadley
    Msaddek, Moncef
    Liagre, Bertrand
    Veitia, Maite Sylla-Iyarreta
    CHEMMEDCHEM, 2024, 19 (21)
  • [22] Metformin attenuates cells stemness and epithelial-mesenchymal transition in colorectal cancer cells by inhibiting the Wnt3a/-catenin pathway
    Zhang, Chu
    Wang, Yuchen
    MOLECULAR MEDICINE REPORTS, 2019, 19 (02) : 1203 - 1209
  • [23] Wnt3a but not CDX-2 expression is associated with differentiated thyroid cancer
    Biagini, Gleyne Lopes Kujew
    Ribas, Carmem Australia Paredes Marcondes
    Higashi, Henrique Diez
    Hirata, Vanessa Yumi
    Zella, Maria Augusta Karas
    Bartolomei, Ivan
    Biagini, Giuliana
    Collaco, Luiz Martins
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2022, 68 (03): : 400 - 404
  • [24] Wnt3a and Wnt3 during AER formation of chick embryos
    Narita, Tomohiro
    Wada, Naoyuki
    Nishimatsu, Shin-Ichiro
    Nohno, Tsutomu
    ZOOLOGICAL SCIENCE, 2006, 23 (12) : 1185 - 1185
  • [25] Mammalian Wnt3a is Released on Lipoprotein Particles
    Neumann, Sylvia
    Coudreuse, Damien Y. M.
    van der Westhuyzen, Deneys R.
    Eckhardt, Erik R. M.
    Korswagen, Hendrik C.
    Schmitz, Gerd
    Sprong, Hein
    TRAFFIC, 2009, 10 (03) : 334 - 343
  • [26] The acceleration of implant osseointegration by liposomal Wnt3a
    Popelut, Antoine
    Rooker, Scott M.
    Leucht, Philipp
    Medio, Marie
    Brunski, John B.
    Helms, Jill A.
    BIOMATERIALS, 2010, 31 (35) : 9173 - 9181
  • [27] The Wnt3a targetome in triple-negative breast cancer cell lines
    Maubant, Sylvie
    Tesson, Bruno
    Maire, Virginie
    Ye, Mengliang
    Rigaill, Guillem
    Gentien, David
    Cruzalegui, Francisco
    Tucker, Gordon C.
    Roman-Roman, Sergio
    Dubois, Thierry
    CANCER RESEARCH, 2015, 75
  • [28] Isolation and characterization of recombinant murine Wnt3a
    Witkowski, Andrzej
    Krishnamoorthy, Aparna
    Su, Betty
    Beckstead, Jennifer A.
    Ryan, Robert O.
    PROTEIN EXPRESSION AND PURIFICATION, 2015, 106 : 41 - 48
  • [29] Targeting lncRNA/Wnt axis by flavonoids: A promising therapeutic approach for colorectal cancer
    Han, Shuai
    Cao, Yunyun
    Guo, Tianyi
    Lin, Qinlu
    Luo, Feijun
    PHYTOTHERAPY RESEARCH, 2022, 36 (11) : 4024 - 4040
  • [30] WNT Unrelated Activities in Commercially Available Preparations of Recombinant WNT3a
    Cajanek, Lukas
    Adlerz, Linda
    Bryja, Vitezslav
    Arenas, Ernest
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2010, 111 (05) : 1077 - 1079
12345